Guifeng Lin

1.3k citations
26 papers · 470 · h-index 11

Impact in

  • Geriatrics and Gerontology top 10%
  • Molecular Biology
    • Inflammasome and immune disorders
    • Receptor Mechanisms and Signaling
    • CRISPR and Genetic Engineering
    • Cell death mechanisms and regulation
    • RNA modifications and cancer

Papers in

  • Molecular Biology 17
    • Receptor Mechanisms and Signaling 4
    • DNA Repair Mechanisms 3
    • Cancer-related gene regulation 3
    • Cancer therapeutics and mechanisms 3
    • Inflammasome and immune disorders 3
    • Ubiquitin and proteasome pathways 2
  • Pharmacology 4
    • Cannabis and Cannabinoid Research 4
Co-authors
Shengyong Yang (18 shared papers)Linli Li (15 shared papers)Anjie Xia (14 shared papers)Jingming Liu (10 shared papers)Luyi Huang (4 shared papers)Shenzhen Huang (3 shared papers)Xin Yang (5 shared papers)Yangli Zhou (5 shared papers)
Journals
Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Medicinal Chemistry (4 papers)European Journal of Medicinal Chemistry (2 papers)Advanced Science (1 paper)International Immunopharmacology (1 paper)
Partner nations
ChinaThailandUnited States

In The Last Decade

Guifeng Lin

26 papers receiving 467 citations

Peers

Guifeng Lin
Comparison fields: 5 of 79
  • Geriatrics and Gerontology 22
  • Molecular Biology 324
  • Physiology 18
  • Soil Science 33
  • Business and International Management 6
Replace Chenchu Lin with:
Chenchu Lin United States
Verena Paulitschke Austria
Clark C. Fjeld United States
Fabio Manzo Italy
Olga Abramczyk United States
Hannah Wapenaar Netherlands
Boxiao Ding United States
Guifeng Lin relative to Chenchu Lin United States Chenchu Lin's profile →
Citations per field
00.5×2×3×
Chenchu Lin · 1×
Citations per year

Countries citing papers authored by Guifeng Lin

Since Specialization
Citations

This map shows the geographic impact of Guifeng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guifeng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guifeng Lin more than expected).

Fields of papers citing papers by Guifeng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guifeng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guifeng Lin. The network helps show where Guifeng Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Guifeng Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guifeng Lin Line = papers co-authored together Guifeng Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
Nature Chemical Biology ·Xin Yang, Xuehui Wang, Zheng Xu, Chao Wu, Yangli Zhou, Yifei Wang, Guifeng Lin, Kan Li, Ming Wu, Anjie Xia, Jingming Liu, Lin Cheng, Jun Zou, Wei Yan, Zhenhua Shao, Shengyong Yang
202268
2
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
Molecular Therapy — Nucleic Acids ·Nan Liu, Lifang Zhou, Guifeng Lin, Yun Hu, Yaoge Jiao, Yanhong Wang, Jingming Liu, Shengyong Yang, Shaohua Yao
202247
3
Discovery of a novel and potent inhibitor with differential species-specific effects against NLRP3 and AIM2 inflammasome-dependent pyroptosis
European Journal of Medicinal Chemistry ·Jiao Yan, Jinshan Nan, Bo Mu, Yun Zhang, Nenghua Zhou, Shunhua Yang, (unknown), Shanshan Zhang, Wan-Ting Lin, Falu Wang, Anjie Xia, Zhixing Cao, Pei Chen, Zhiling Pan, Guifeng Lin, Shulei Pan, Huachao Bin, Linli Li, Shengyong Yang
202246
4
Inhibition of METTL3 Alleviates NLRP3 Inflammasome Activation via Increasing Ubiquitination of NEK7
Advanced Science ·Xinyi Zhou, Xiaoyu Yang, Shenzhen Huang, Guifeng Lin, Kexin Lei, Qian Wang, Weimin Lin, Hanwen Li, Xingying Qi, Dutmanee Seriwatanachai, Shengyong Yang, Bin Shao, Quan Yuan
202439
5
Discovery of Potent and Selective Inhibitors of Cdc2-Like Kinase 1 (CLK1) as a New Class of Autophagy Inducers
Journal of Medicinal Chemistry ·Qizheng Sun, Guifeng Lin, Linli Li, Xi-Ting Jin, Luyi Huang, Guo Zhang, Wei Yang, Kai Chen, Rong Xiang, Chong Chen, (unknown), Guangwen Lu, Shengyong Yang
201737
6
Linking microbial immobilization of fertilizer nitrogen to in situ turnover of soil microbial residues in an agro-ecosystem
Agriculture Ecosystems & Environment ·Xiao Liu, Guoqing Hu, Hongbo He, Chao Liang, Wei Zhang, Zhen Bai, Yeye Wu, Guifeng Lin, Xudong Zhang
201637
7
Identification of 5-(2,3-Dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model
Journal of Medicinal Chemistry ·Yueshan Li, Yu Xiong, Guo Zhang, Liting Zhang, Wei Yang, Jiao Yang, Luyi Huang, Zeen Qiao, Zhuang Miao, Guifeng Lin, Qiu Sun, Ting Niu, Lijuan Chen, Dawen Niu, Linli Li, Shengyong Yang
201837
8
Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain
Angewandte Chemie International Edition ·Yinping Guo, Xin Mao, Liang Xiong, Anjie Xia, Jing You, Guifeng Lin, Chengyong Wu, Luyi Huang, Yiwei Wang, Shengyong Yang
202133
9
Discovery of Potent Small-Molecule SIRT6 Activators: Structure–Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity
Journal of Medicinal Chemistry ·Xiuli Chen, Weining Sun, Shenzhen Huang, Hailin Zhang, Guifeng Lin, Hui Li, Jingxin Qiao, Linli Li, Shengyong Yang
202027
10
Discovery of a potent and highly selective inhibitor of ataxia telangiectasia mutated and Rad3-Related (ATR) kinase: Structural activity relationship and antitumor activity both in vitro and in vivo
European Journal of Medicinal Chemistry ·Huachao Bin, Pei Chen, Ming Wu, Falu Wang, Guifeng Lin, Shulei Pan, Jingming Liu, Bo Mu, Jinshan Nan, Qiao Huang, Linli Li, Shengyong Yang
202217
11
Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1
Proceedings of the National Academy of Sciences ·Siyuan Shen, Chao Wu, Guifeng Lin, Xin Yang, Yangli Zhou, Chang Zhao, Zhuang Miao, Xiaowen Tian, Kexin Wang, Zhiqian Yang, Zhiyu Liu, Nihong Guo, Yueshan Li, Anjie Xia, Pei Zhou, Jingming Liu, Wei Yan, Bowen Ke, Shengyong Yang, Zhenhua Shao
202413
12
Discovery of 6,7-dihydro-5H-pyrrolo[3,4-d] pyrimidine derivatives as a new class of ATR inhibitors
Bioorganic & Medicinal Chemistry Letters ·Pei Chen, Huachao Bin, Yan Jiao, Guifeng Lin, Yun Zhang, Anjie Xia, Zhilin Pan, Jingxin Qiao, Yinping Guo, Jingming Liu, Yangli Zhou, Linli Li
20228
13
Discovery of 1,8-disubstituted-[1,2,3]triazolo[4,5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors
Bioorganic & Medicinal Chemistry Letters ·Jingxin Qiao, Guifeng Lin, Anjie Xia, Zhiyu Xiang, Pei Chen, Guo Zhang, Linli Li, Shengyong Yang
20198
14
Discovery of Small Molecule Agonist of Gonadotropin-Releasing Hormone Receptor (GnRH1R)
Journal of Chemical Information and Modeling ·Xin Yang, Guifeng Lin, Anjie Xia, Jingming Liu, Shiyu Zhang, Pei Zhou, Yiwei Wang, Jiahao Zhang, Yangli Zhou, Pei Chen, Yifei Wang, Tao Zheng, Linli Li, Shengyong Yang
20227
15
Discovery of a novel pyroptosis inhibitor acting though modulating glutathionylation to suppress NLRP3-related signal pathway
International Immunopharmacology ·Nenghua Zhou, Yun Zhang, Jiao Yan, Jinshan Nan, Anjie Xia, Bo Mu, Guifeng Lin, Xun Li, Shanshan Zhang, Shengyong Yang, Linli Li
20236
16
Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain
Journal of Medicinal Chemistry ·Jinshan Nan, Jingming Liu, Guifeng Lin, Shanshan Zhang, Anjie Xia, Pei Zhou, Yangli Zhou, Jiahao Zhang, Jinlong Zhao, Shiyu Zhang, Chong Huang, Yifei Wang, Qian Hu, Junxian Chen, Mingli Xiang, Xin Yang, Shengyong Yang
20236
17
Targeting Noncanonical Pyroptosis With a Small Molecular Inhibitor Alleviates Inflammation in the LPS-Induced Keratitis Mouse Model
Investigative Ophthalmology & Visual Science ·Yun Zhang, Nenghua Zhou, Jiao Yan, Guifeng Lin, Xun Li, Sheng Gao, Pei Zhou, Jingming Liu, Jinshan Nan, Meixia Zhang, Shengyong Yang
20236
18
Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors
Bioorganic & Medicinal Chemistry Letters ·Yun Zhang, Anjie Xia, Shiyu Zhang, Guifeng Lin, Jingming Liu, Pei Chen, Bo Mu, Yan Jiao, Wenwen Xu, Mingxin Chen, Linli Li
20215
19
Discovery of [1,2,3]Triazolo[4,5-c]quinoline Derivatives as a New Class of Ataxia-Telangiectasia Mutated Kinase Inhibitors
ACS Medicinal Chemistry Letters ·Shiyu Zhang, Pei Zhou, Jingming Liu, Anjie Xia, Guifeng Lin, Zhiyu Xiang, Zhen Fang, Xin Yang, Jingxin Qiao, Qian Hu, Jiahao Zhang, Jinlong Zhao, Linli Li
20235
20
Discovery of 3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucoma
Bioorganic & Medicinal Chemistry Letters ·Yumeng Sun, Yueshan Li, Zhuang Miao, Ruicheng Yang, Yun Zhang, Ming Wu, Guifeng Lin, Linli Li
20215

About Guifeng Lin

Guifeng Lin is a scholar working on Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience, Oncology and Epidemiology, having authored 26 papers that have together received 470 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (4 papers), Receptor Mechanisms and Signaling (4 papers), DNA Repair Mechanisms (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Cancer-related gene regulation (3 papers), Cancer therapeutics and mechanisms (3 papers), Inflammasome and immune disorders (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Geriatrics and Gerontology (22 citations), Molecular Biology (324 citations), Physiology (18 citations), Soil Science (33 citations) and Business and International Management (6 citations). Guifeng Lin has collaborated with scholars based in China, Thailand and United States. Frequent co-authors include Shengyong Yang, Linli Li, Anjie Xia, Jingming Liu, Luyi Huang, Shenzhen Huang, Xin Yang, Yangli Zhou, Lifang Zhou and Nan Liu. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Advanced Science and International Immunopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chenchu LinBreakdown of academic impact, for papers by Verena PaulitschkeBreakdown of academic impact, for papers by Clark C. FjeldBreakdown of academic impact, for papers by Fabio ManzoBreakdown of academic impact, for papers by Olga AbramczykBreakdown of academic impact, for papers by Hannah WapenaarBreakdown of academic impact, for papers by Boxiao Ding